EUVIMEDEUVIMED entdecken
Crossref

Associations among the TREM-1 Pathway, Tau Hyperphosphorylation, Prolactin Expression, and Metformin in Diabetes Mice

Hai Duc Nguyen, Ngoc Minh Hong Hoang, Won Hee Jo, Ju Ri Ham, Mi-Kyung Lee, Min Sun Kim

Neuroimmunomodulation · 2022 · 29 (4) · 359-368

DOI: 10.1159/000521013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuroimmunomodulation, online erschienen am 07.02.2022. Verfasst von Hai Duc Nguyen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Sunchon, Republi…. Hauptthemen laut MEDLINE: Alzheimer Disease, Diabetes Mellitus, Metformin, Prolactin. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Diabetes mellitus (DM) is a risk factor for Alzheimer’s disease (AD). Increasing evidence indicates that the triggering receptor expressed on myeloid cells (TREM)-1 amplifies chronic inflammation, as well as the roles of prolactin (PRL) and metformin (MET) in tau hyperphosphorylation. However, the associations among TREM-1, tau hyperphosphorylation, PRL expression, and MET in DM remain unclear.

Methods

Streptozotocin was used to induce experimental DM in C57BL/6N mice. MET was orally administered at a dose of 400 mg/kg body weight for 6 weeks prior to hippocampal collection in DM mice. Various parameters pertaining to the TREM-1 pathway, tau hyperphosphorylation, PRL, and related factors were analyzed.

Results

Quantitative polymerase chain reaction and Western blot analysis demonstrated that the expression levels of TREM-1, DAP12, casp1, interleukin-1β, Cox2, inducible nitric oxide synthase, pituitary transcriptional factor-1 (Pit-1), and PRL were significantly increased in the hippocampus of DM mice; the expression levels of these pro-inflammatory mediators, PRL receptor (PRLR) short or long (PRLR-S and PRLR-L), and PRL regulatory element-binding (Preb) protein in DM mice treated with MET (DM + MET) were significantly decreased compared with those in control (CON) mice. The levels of p-Tau and glycogen synthase kinase-3 in the DM group were significantly higher than those in the CON group and significantly lower than those in the DM + MET group.

Conclusion

We confirmed the therapeutic potential of MET for both DM and neurodegeneration. Our findings shed new light on the effects of DM on the pathophysiology of AD via the TREM-1 pathway and PRL expression. Thus, an improved understanding of the TREM-1 pathway in hyperglycemic conditions, as well as PRL, Preb, Pit-1, PRLR-L, and PRLR-S gene expression in the liver, brain, and other sites, may help unravel the pathogenesis of insulin resistance and neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDiabetes MellitusMetforminProlactinAnimalsMiceMice, Inbred C57BLReceptors, ProlactinTriggering Receptor Expressed on Myeloid Cells-1PhosphorylationHippocampustau Proteins

Stichwörter der Autor:innen

Alzheimer’s diseaseDiabetesMetforminProlactinTau hyperphosphorylationp-Tau

Substanzen

MetforminProlactinReceptors, ProlactinTriggering Receptor Expressed on Myeloid Cells-1TREM1 protein, mouseMapt protein, mousetau Proteins

Autor:innen und Institutionen

  • Department of Pharmacy, College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Sunchon, Republic of Korea.
  • Department of Food and Nutrition, Sunchon National University, Suncheon, Republic of Korea.
  • Mokpo Marine Food-Industry Research Center, Mokpo, Jeonam, Republic of Korea.

Zitieren

APA

Duc Nguyen, H., Hoang, N. M. H., Jo, W. H., Ham, J. R., Lee, M. K., & Kim, M. S. (2022). Associations among the TREM-1 Pathway, Tau Hyperphosphorylation, Prolactin Expression, and Metformin in Diabetes Mice. Neuroimmunomodulation, 29(4), 359-368. https://doi.org/10.1159/000521013

Vancouver

Duc Nguyen H, Hoang NMH, Jo WH, Ham JR, Lee MK, Kim MS. Associations among the TREM-1 Pathway, Tau Hyperphosphorylation, Prolactin Expression, and Metformin in Diabetes Mice. Neuroimmunomodulation. 2022;29(4):359-368. doi:10.1159/000521013

BibTeX
@article{DucNguyen2022,
  author = {Duc Nguyen, Hai and Hoang, Ngoc Minh Hong and Jo, Won Hee and Ham, Ju Ri and Lee, Mi-Kyung and Kim, Min Sun},
  title = {Associations among the TREM-1 Pathway, Tau Hyperphosphorylation, Prolactin Expression, and Metformin in Diabetes Mice},
  journal = {Neuroimmunomodulation},
  year = {2022},
  volume = {29},
  number = {4},
  pages = {359--368},
  doi = {10.1159/000521013}
}
Kostenlos starten →